Don M Benson

Don M Benson

UNVERIFIED PROFILE

Are you Don M Benson?   Register this Author

Register author
Don M Benson

Don M Benson

Publications by authors named "Don M Benson"

Are you Don M Benson?   Register this Author

87Publications

3016Reads

48Profile Views

Lenalidomide and Vorinostat Maintenance after Autologous Transplantation in Multiple Myeloma: Long- Term Follow-Up.

Biol Blood Marrow Transplant 2020 Jan 10;26(1):44-49. Epub 2019 Sep 10.

Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.09.005DOI Listing
January 2020

Comparison of Two Doses of Antithymocyte Globulin in Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation.

Biol Blood Marrow Transplant 2019 Oct 20;25(10):1993-2001. Epub 2019 Jun 20.

Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.06.014DOI Listing
October 2019

The Mechanism of Anti-PD-L1 Antibody Efficacy against PD-L1-Negative Tumors Identifies NK Cells Expressing PD-L1 as a Cytolytic Effector.

Cancer Discov 2019 Oct 24;9(10):1422-1437. Epub 2019 Jul 24.

Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-18-1259DOI Listing
October 2019

Tocilizumab as first-line therapy for steroid-refractory acute graft-versus-host-disease: analysis of a single-center experience.

Leuk Lymphoma 2019 Sep 15;60(9):2223-2229. Epub 2019 Feb 15.

Department of Pharmacy, The James Cancer Hospital, The Ohio State University Comprehensive Cancer Center , Columbus , Ohio , 43210 , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1573996DOI Listing
September 2019

Potential of NK cells in multiple Myeloma therapy.

Expert Rev Hematol 2019 Jun 22;12(6):425-435. Epub 2019 May 22.

a Division of Hematology, Department of Medicine , The Ohio State University Comprehensive Cancer Center , Columbus , OH , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17474086.2019.1617128DOI Listing
June 2019

Most multiple myeloma patients have low testosterone.

Leuk Lymphoma 2019 03 2;60(3):836-838. Epub 2018 Oct 2.

b Division of Hematology, Department of Internal Medicine , The Ohio State University , Columbus , OH , USA.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/10428194.2018.1
Publisher Site
http://dx.doi.org/10.1080/10428194.2018.1508664DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6445785PMC
March 2019

Ninety-minute daratumumab infusion is safe in multiple myeloma.

Leukemia 2018 11 31;32(11):2495-2518. Epub 2018 Mar 31.

Department of Internal Medicine, Division of Hematology, Ohio State University, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-018-0120-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167208PMC
November 2018

Fratricide of NK Cells in Daratumumab Therapy for Multiple Myeloma Overcome by -Expanded Autologous NK Cells.

Clin Cancer Res 2018 08 17;24(16):4006-4017. Epub 2018 Apr 17.

The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-17-3117DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6095810PMC
August 2018

A phase 1b study of isatuximab plus lenalidomide and dexamethasone for relapsed/refractory multiple myeloma.

Blood 2017 06 8;129(25):3294-3303. Epub 2017 May 8.

Section of Bone Marrow Transplantation & Leukemia, Division of Oncology, Department of Medicine, Washington University, St. Louis, MO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2016-09-740787DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482100PMC
June 2017

Checkpoint inhibition in myeloma.

Authors:
Don M Benson

Hematology Am Soc Hematol Educ Program 2016 Dec;2016(1):528-533

Department of Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2016.1.528DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142496PMC
December 2016

Tocilizumab for steroid refractory acute graft-versus-host disease.

Leuk Lymphoma 2016 3;57(1):81-5. Epub 2015 Jul 3.

b Division of Hematology, Department of Internal Medicine , James Cancer Hospital, The Ohio State University Comprehensive Cancer Center , Columbus , Ohio , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2015.1045896DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4698359PMC
October 2016

Lenalidomide and vorinostat maintenance after autologous transplant in multiple myeloma.

Br J Haematol 2015 Oct 8;171(1):74-83. Epub 2015 Jun 8.

Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13527DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4600596PMC
October 2015

The transcription Factor AHR prevents the differentiation of a stage 3 innate lymphoid cell subset to natural killer cells.

Cell Rep 2014 Jul 19;8(1):150-62. Epub 2014 Jun 19.

Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH 43210, USA; Integrated Biomedical Graduate Program, Medical Scientist Program, The Ohio State University, Columbus, OH 43210, USA; Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA; The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH 43210, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2014.05.042DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4133146PMC
July 2014

A phase I trial of flavopiridol in relapsed multiple myeloma.

Cancer Chemother Pharmacol 2014 Feb 16;73(2):249-57. Epub 2013 Nov 16.

Division of Hematology, The Ohio State University, B321 Starling Loving Hall, 320 West 10th Avenue, Columbus, OH, 43210, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-013-2347-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946636PMC
February 2014

Long-Term Therapy with Lenalidomide in a Patient with POEMS Syndrome.

Eur J Case Rep Intern Med 2014;1

Division of Hematology, Department of Internal Medicine, Ohio State University, Columbus, OH, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12890/2014_000093DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4326104PMC
January 2014

Characterization of multiple myeloma vesicles by label-free relative quantitation.

Proteomics 2013 Oct;13(20):3013-29

Department of Molecular Virology, Immunology and Medical Genetics, The Ohio State University, Columbus, OH, USA; Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pmic.201300142DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835174PMC
October 2013

Can NKT cells extinguish smoldering myeloma?

Authors:
Don M Benson

Blood 2013 Jan;121(3):418-20

The Ohio State University Comprehensive Cancer Center.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2012-11-465849DOI Listing
January 2013

The role of natural killer cells in immunity against multiple myeloma.

Leuk Lymphoma 2012 Sep 19;53(9):1666-76. Epub 2012 Apr 19.

The Ohio State University College of Medicine, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2012.676175DOI Listing
September 2012

CS1-directed monoclonal antibody therapy for multiple myeloma.

J Clin Oncol 2012 Jun 30;30(16):2013-5. Epub 2012 Apr 30.

The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2011.40.4061DOI Listing
June 2012

A small molecule, LLL12 inhibits constitutive STAT3 and IL-6-induced STAT3 signaling and exhibits potent growth suppressive activity in human multiple myeloma cells.

Int J Cancer 2012 Mar 26;130(6):1459-69. Epub 2011 Aug 26.

Department of Pediatrics, Center for Childhood Cancer, The Research Institute at Nationwide Children's Hospital, Columbus, OH 43205, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.26152DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3228889PMC
March 2012

CD94 defines phenotypically and functionally distinct mouse NK cell subsets.

J Immunol 2009 Oct;183(8):4968-74

Department of Molecular Virology, Immunology, and Medical Genetics, The Ohio State University, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.0900907DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2924742PMC
October 2009

Curcumin induces proapoptotic effects against human melanoma cells and modulates the cellular response to immunotherapeutic cytokines.

Mol Cancer Ther 2009 Sep 1;8(9):2726-35. Epub 2009 Sep 1.

Department of Internal Medicine, Division of Hematology and Oncology, 302B Comprehensive Cancer Center, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-09-0377DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2748163PMC
September 2009

Allogeneic stem cell transplantation for patients with relapsed chemorefractory aggressive non-hodgkin lymphomas.

Biol Blood Marrow Transplant 2009 May 9;15(5):547-53. Epub 2009 Mar 9.

Hematology and Oncology, Arthur G James Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2009.01.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3953134PMC
May 2009

High-dose therapy and autologous stem cell transplantation for follicular lymphoma undergoing transformation to diffuse large B-cell lymphoma.

Eur J Haematol 2008 Dec 4;81(6):425-31. Epub 2008 Sep 4.

Department of Internal Medicine, Division of Hematology-Oncology, Arthur G James Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1600-0609.2008.01146.xDOI Listing
December 2008

Catecholamines can mediate stress-related effects on tumor progression.

Expert Rev Endocrinol Metab 2008 Nov;3(6):699-703

c Department of Molecular Virology, Immunology and Medical Genetics; Comprehensive Cancer Center; Department of Internal Medicine; Institute for Behavioral Medicine Research, The Ohio State University Medical Center, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/17446651.3.6.699DOI Listing
November 2008

Feasibility of allogeneic hematopoietic stem cell transplantation for follicular lymphoma undergoing transformation to diffuse large B-cell lymphoma.

Leuk Lymphoma 2008 Oct;49(10):1893-8

Department of Hematology and Oncology and Bone Marrow Transplantation, The Ohio State University, Columbus, Ohio 43210, USA.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1080/1042819080227090
Publisher Site
http://dx.doi.org/10.1080/10428190802270902DOI Listing
October 2008

Activation of extracellular signaling regulated kinase in natural killer cells and monocytes following IL-2 stimulation in vitro and in patients undergoing IL-2 immunotherapy: analysis via dual parameter flow-cytometric assay.

Cancer Immunol Immunother 2008 Aug 10;57(8):1137-49. Epub 2008 Jan 10.

Human Cancer Genetics Program, Department of Molecular Virology, Immunology and Medical Genetics, The Ohio State University, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-007-0444-7DOI Listing
August 2008

VEGF is differentially regulated in multiple myeloma-derived cell lines by norepinephrine.

Brain Behav Immun 2008 Mar 5;22(3):318-23. Epub 2007 Nov 5.

Department of Molecular Virology, Immunology and Medical Genetics, The Ohio State University Medical Center, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbi.2007.09.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2259392PMC
March 2008

High-dose melphalan versus busulfan, cyclophosphamide, and etoposide as preparative regimens for autologous stem cell transplantation in patients with multiple myeloma.

Leuk Res 2007 Aug 30;31(8):1069-75. Epub 2006 Oct 30.

Division of Hematology and Oncology, Department of Internal Medicine, The Ohio State University College of Medicine, Comprehensive Cancer Center, Starling-Loving Hall, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2006.09.021DOI Listing
August 2007

Gastrointestinal stromal tumors involving the prostate: presentation, course, and therapeutic approach.

Urology 2007 Jun;69(6):1209.e5-7

Department of Internal Medicine, Division of Hematology/Oncology, Ohio State University, Columbus, Ohio 43210-1280, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2007.03.029DOI Listing
June 2007

Thalidomide-induced fulminant hepatic failure.

Mayo Clin Proc 2007 May;82(5):638

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4065/82.5.638DOI Listing
May 2007

A phase I study of ultra low dose interleukin-2 and stem cell factor in patients with HIV infection or HIV and cancer.

Clin Cancer Res 2006 Jul;12(13):3993-6

Division of Hematology/Oncology, Department of Internal Medicine, Ohio State University, Columbus, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-06-0268DOI Listing
July 2006

Open-chest CPR improves survival and neurologic outcome following cardiac arrest.

Resuscitation 2005 Feb;64(2):209-17

Department of Emergency Medicine, St. John Hospital and Medical Center, 22101 Moross Road, Detroit, MI 48236, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.resuscitation.2003.03.001DOI Listing
February 2005